Top Markets
Coin of the day
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Rankning i aktier #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Aktiekurs
$11.03
Senast synkroniserad: 2026-08-28
Marknadsvärde
$597.15M
Förändring (1 dag)
-4.25%
Förändring (1 år)
-
Land
US
Handel Eikon Therapeutics, Inc. Common Stock (EIKN)

Kategori

Aktiekurshistorik för Eikon Therapeutics, Inc. Common Stock (EIKN)
Högsta slutkurs: $10.87 den 2026-08-01

Lägsta slutkurs: $14.75 den 2026-02-01
Aktiekurshistorik för Eikon Therapeutics, Inc. Common Stock från 2026 till 2026
Årlig aktiekursutveckling
År Prestanda
Inte tillräckligt med data för de angivna datumen.
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$120.75 -13.26%
AU
$138.18 473.58%
US
$759.27 7.20%
CH